TY - JOUR
T1 - Association of the Timing and Type of Acute Symptomatic Seizures With Poststroke Epilepsy and Mortality
AU - Schubert, Kai Michael
AU - Zieglgänsberger, Dominik
AU - Bicciato, Giulio
AU - Abraira, Laura
AU - Santamarina, Estevo
AU - Álvarez-Sabín, José
AU - Ferreira-Atuesta, Carolina
AU - Katan, Mira
AU - Sinka, Lucia
AU - Terziev, Robert
AU - Deligas, Nico
AU - Erdélyi-Canavese, Barbara
AU - Felbecker, Ansgar
AU - Siebel, Philip
AU - Winklehner, Michael
AU - von Oertzen, Tim J
AU - Wagner, Judith N
AU - Gigli, Gian Luigi
AU - Nilo, Annacarmen
AU - Janes, Francesco
AU - Merlino, Giovanni
AU - Valente, Mariarosaria
AU - Zafra-Sierra, María Paula
AU - Mayor-Romero, Luis Carlos
AU - Conrad, Julian
AU - Evers, Stefan
AU - Alet, Matias
AU - Fukuma, Kazuki
AU - Ihara, Masafumi
AU - Landau, Benjamin
AU - Lochner, Piergiorgio
AU - Roell, Frauke
AU - Brigo, Francesco
AU - Bentes, Carla
AU - Peralta, Ana Rita
AU - Pinho E Melo, Teresa
AU - Keezer, Mark R
AU - Duncan, John S
AU - Sander, Josemir W
AU - Tettenborn, Barbara
AU - Koepp, Matthias J
AU - Galovic, Marian
PY - 2025/4/25
Y1 - 2025/4/25
N2 - BACKGROUND: Acute symptomatic seizures (ASyS) increase the risk of epilepsy and mortality after a stroke. The impact of the timing and type of ASyS remains unclear.METHODS: This multicenter cohort study included data from 9 centers between 2002 and 2018, with a final analysis in February 2024. The study included 4552 adults (2005 female; median age, 73 years) with ischemic stroke and no seizure history. Seizures were classified using International League Against Epilepsy definitions. We examined ASyS occurring within 7 days after stroke. The main outcomes were all-cause mortality and epilepsy. Validation of the updated SeLECT score (SeLECT-ASyS) was performed in 3 independent cohorts (Switzerland, Argentina, and Japan) collected between 2012 and 2024, including 74 adults with ASyS.RESULTS: The 10-year risk of poststroke epilepsy ranged from 41% to 94%, and mortality from 36% to 100%, depending on ASyS type and timing. ASyS on stroke onset day had a higher epilepsy risk (adjusted hazard ratio [aHR], 2.3 [95% CI, 1.3-4.0]; P=0.003) compared with later ASyS. Status epilepticus had the highest epilepsy risk (aHR, 9.6 [95% CI, 3.5-26.7]; P<0.001), followed by focal to bilateral tonic-clonic seizures (aHR, 3.4 [95% CI, 1.9-6.3]; P<0.001). Mortality was higher in those with ASyS presenting as focal to bilateral tonic-clonic seizures on day 0 (aHR, 2.8 [95% CI, 1.4-5.6]; P=0.004) and status epilepticus (aHR, 14.2 [95% CI, 3.5-58.8]; P<0.001). The updated SeLECT-ASyS model, available as an application, outperformed a previous model in the derivation cohort (concordance statistics, 0.68 versus 0.58; P=0.02) and in the validation cohort (0.70 versus 0.50; P=0.18).CONCLUSIONS: ASyS timing and type significantly affect epilepsy and mortality risk after stroke, improving epilepsy prediction and guiding patient counseling.
AB - BACKGROUND: Acute symptomatic seizures (ASyS) increase the risk of epilepsy and mortality after a stroke. The impact of the timing and type of ASyS remains unclear.METHODS: This multicenter cohort study included data from 9 centers between 2002 and 2018, with a final analysis in February 2024. The study included 4552 adults (2005 female; median age, 73 years) with ischemic stroke and no seizure history. Seizures were classified using International League Against Epilepsy definitions. We examined ASyS occurring within 7 days after stroke. The main outcomes were all-cause mortality and epilepsy. Validation of the updated SeLECT score (SeLECT-ASyS) was performed in 3 independent cohorts (Switzerland, Argentina, and Japan) collected between 2012 and 2024, including 74 adults with ASyS.RESULTS: The 10-year risk of poststroke epilepsy ranged from 41% to 94%, and mortality from 36% to 100%, depending on ASyS type and timing. ASyS on stroke onset day had a higher epilepsy risk (adjusted hazard ratio [aHR], 2.3 [95% CI, 1.3-4.0]; P=0.003) compared with later ASyS. Status epilepticus had the highest epilepsy risk (aHR, 9.6 [95% CI, 3.5-26.7]; P<0.001), followed by focal to bilateral tonic-clonic seizures (aHR, 3.4 [95% CI, 1.9-6.3]; P<0.001). Mortality was higher in those with ASyS presenting as focal to bilateral tonic-clonic seizures on day 0 (aHR, 2.8 [95% CI, 1.4-5.6]; P=0.004) and status epilepticus (aHR, 14.2 [95% CI, 3.5-58.8]; P<0.001). The updated SeLECT-ASyS model, available as an application, outperformed a previous model in the derivation cohort (concordance statistics, 0.68 versus 0.58; P=0.02) and in the validation cohort (0.70 versus 0.50; P=0.18).CONCLUSIONS: ASyS timing and type significantly affect epilepsy and mortality risk after stroke, improving epilepsy prediction and guiding patient counseling.
KW - Humans
KW - Female
KW - Male
KW - Aged
KW - Epilepsy/mortality
KW - Middle Aged
KW - Seizures/mortality
KW - Stroke/complications
KW - Aged, 80 and over
KW - Cohort Studies
KW - Time Factors
KW - Risk Factors
UR - https://www.scopus.com/pages/publications/105003693550
U2 - 10.1161/STROKEAHA.124.050045
DO - 10.1161/STROKEAHA.124.050045
M3 - Article
C2 - 40270248
SN - 1524-4628
VL - 56
SP - 1748
EP - 1757
JO - Stroke
JF - Stroke
IS - 7
ER -